Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 8,790 | 15,332 | 14,346 | 4,706 | 2,019 |
| Gross Profit | 8,790 | 15,332 | 14,346 | 4,706 | 2,019 |
| Operating Expenses | 33,895 | 26,069 | 20,729 | 19,051 | 27,961 |
| Operating Income | -25,105 | -10,737 | -6,383 | -14,345 | -25,942 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 19,876 | -15,935 | -6,444 | 320 | -1,053 |
| Pre-tax Income | -5,230 | -26,672 | -12,826 | -14,026 | -26,997 |
| Net Income Continuous | -5,230 | -26,672 | -12,826 | -14,026 | -26,997 |
| Minority Interests | -1,216 | -306 | 0 | N/A | N/A |
| Net Income | $-4,014 | $-26,366 | $-12,826 | $-14,026 | $-26,997 |
| EPS Basic Total Ops | -2.40 | -20.20 | -16.40 | -22.60 | -46.80 |
| EPS Basic Continuous Ops | -3.21 | -20.37 | -15.64 | -20.79 | -44.66 |
| EPS Diluted Total Ops | -2.40 | -20.20 | -16.40 | -22.60 | -46.80 |
| EPS Diluted Continuous Ops | -3.21 | -20.37 | -15.64 | -20.79 | -44.66 |
| EBITDA(a) | $-24,580 | $-10,330 | $-6,021 | $-14,021 | $-25,754 |